XML 30 R17.htm IDEA: XBRL DOCUMENT v3.8.0.1
EMPLOYEE EQUITY INCENTIVE PLAN
12 Months Ended
Dec. 31, 2017
Employee Equity Incentive Plan  
EMPLOYEE EQUITY INCENTIVE PLAN

NOTE 11 – EMPLOYEE EQUITY INCENTIVE PLANS

 

The Company’s stockholders approved our 2014 Equity Incentive Plan in June 2014 (the “2014 Plan”), our 2015 Equity Incentive Plan in December 2015 (the “2015 Plan”), our 2016 Equity Incentive Plan (“2016 Plan”) in October 2016 and our 2017 Equity Incentive Plan in December 2016 (“2017 Plan”, and together with the 2014 Plan, 2015 Plan and 2016 Plan, the “Plans”). The Plans are identical, except for number of shares reserved for issuance under each. As of December 31, 2017, the Company had granted an aggregate of 39,500,000 securities under the plans, with 0 available for future issuances.

 

The Plans provide for the grant of incentive stock options to our employees and our parent and subsidiary corporations’ employees, and for the grant of non-statutory stock options, stock bonus awards, restricted stock awards, performance stock awards and other forms of stock compensation to our employees, including officers, consultants and directors. Our Plans also provide that the grant of performance stock awards may be paid out in cash as determined by the committee administering the Plans.

 

During the year ended December 31, 2016, the Company granted options to purchase 9,958,031 for ten years. The fair value of $6,450,317, was determined using the Black-Scholes Option Pricing Model, assuming approximately 1.75% to 2.10% risk-free interest, 0% dividend yield, 107.63% to 119.16% volatility, and expected life of five to ten years and will be charged to operations over the vesting terms of the options.

 

During the year ended December 31, 2017, the Company granted ten-year options to purchase up to 2,854,000 shares of common stock. The fair value of $2,014,591, was determined using the Black-Scholes Option Pricing Model, assuming approximately 1.81% to 2.35% risk-free interest, 0% dividend yield, 103.66% to 110.16% volatility, and expected life of five to ten years and will be charged to operations over the vesting terms of the options.

 

The summary terms of the issuances are as follows:

Exercise   Number of   Vesting
Price   Options   Terms
$ 0.50       80,000     Immediately
  0.50       100,000     Quarterly over one year
  0.50       605,000     Quarterly over two years
  0.81       5,000     Immediately
  0.82       150,000     Quarterly over two years
  0.85       150,000     Quarterly over one year
  0.87       125,000     Immediately
  0.89       425,000     Monthly over one year
  0.89       90,000     Quarterly over two years
  0.95       400,000     Quarterly over two years
  0.98       24,000     Monthly over two years
  1.05       50,000     Immediately
  1.05       95,000     Monthly over two years
  1.05       60,000     Monthly over one year
  1.06       60,000     Monthly over one year
  1.07       110,000     Monthly over one year
  1.07       325,000     Monthly over two years
  0.83       2,854,000      

 

On June 21, 2017, the Company accelerated vesting of 5,000,000 options such that the options vested in full, immediately. As a result, the Company charged $2,544,741 to operations during the twelve months ended December 31, 2017.

 

Stock options outstanding and exercisable on December 31, 2017 are as follows:

Exercise   Number of   Remaining Life   Number of
Price   Options   In Years   Options Exerciseable
$ 0.10       1,056,786       6.43       1,056,786
$ 0.50       689,631       7.74       689,631
$ 0.51 - 0.75       2,267,586       8.69       1,996,779
$ 0.76 - 1.00       9,734,403       8.70       9,233,070
$ 1.01 - 2.00       629,164       8.61       629,164
          14,377,570               13,605,430
                             

 

               

A summary of the stock option activity for the twelve months ended December 31, 2017 is as follows:

                Weighted-Average        
          Weighted-Average     Remaining     Aggregate  
    Shares     Exercise Price     Contractual Term     Intrinsic Value  
Outstanding at December 31, 2015     5,625,000     $ 0.59       9.30     $ 61,875  
Grants     9,958,031       0.78       9.84          
Exercised     (636,780)       0.50       8.80          
Forfeiture/Cancelled     (122,093)       0.55       8.80          
Outstanding at December 31, 2016     14,824,158      $ 0.52       9.37     $ 4,566,717  
Grants     2,854,000       0.50       9.60       -  
Exercised     (436,011     0.16       8.80           
Forfeiture/Canceled     (2,454,761 )   $ 0.73       8.80       -  
Outstanding at December 31, 2017     14,377,570     $ 0.76       8.48     $ 771,359  
Exercisable at December 31, 2017     13,605,430     $ 0.76       8.50     $ 646,109  

 

The aggregate intrinsic value of outstanding stock options was based on options with an exercise price less than the Company’s common stock price of $0.601 as of December 31, 2017, which would have been received by the option holders had those option holders exercised their options as of that date.

 

Option valuation models require the input of highly subjective assumptions. The fair value of stock-based payment awards was estimated using the Black-Scholes option model with a volatility figure derived historical data. The Company accounts for the expected life of options based on the contractual life of options for non-employees.

 

The fair value of all options that were vested as of the year ended December 31, 2017 and 2016 was $5,821,631 and $3,112,156, respectively Unrecognized compensation expense of $173,220 at December 31, 2017 will be expensed in future periods.